Neumora Therapeutics, Inc. (NMRA)
0.3624
+0.03
(+8.34%)
USD |
NASDAQ |
Nov 18, 16:00
0.3624
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Net Income (Quarterly) : -34.44M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -34.44M |
| June 30, 2026 | -43.08M |
| March 31, 2026 | -53.46M |
| December 31, 2025 | -59.45M |
| September 30, 2025 | -56.76M |
| June 30, 2025 | -52.73M |
| March 31, 2025 | -67.99M |
| December 31, 2024 | -58.82M |
| September 30, 2024 | -72.55M |
| June 30, 2024 | -58.70M |
| Date | Value |
|---|---|
| March 31, 2024 | -53.72M |
| December 31, 2023 | -108.73M |
| September 30, 2023 | -53.03M |
| June 30, 2023 | -38.54M |
| March 31, 2023 | -35.62M |
| December 31, 2022 | -28.15M |
| September 30, 2022 | -29.34M |
| June 30, 2022 | -30.37M |
| March 31, 2022 | -43.04M |
| March 31, 2021 | -15.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| EyePoint, Inc. | -95.61M |
| Context Therapeutics, Inc. | -7.624M |
| LENZ Therapeutics, Inc. | -30.97M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 34.44M |
| EPS Diluted (Quarterly) | -0.1833 |
| Enterprise Value | 31.03M |
| Earnings Yield | -294.2% |
| Normalized Earnings Yield | -294.12 |